{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:34:59Z","timestamp":1790753699079,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T00:00:00Z","timestamp":1346889600000},"content-version":"vor","delay-in-days":2866,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obesity Research"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective<\/jats:italic>: The high prevalence of obesity and cardiovascular risk factors in hypopituitarism affirms the need for effective weight loss intervention. In this study, we investigated the combined effect of sibutramine, diet, and exercise in obese hypopituitary patients (HPs).<\/jats:p><jats:p><jats:italic>Research Methods and Procedures<\/jats:italic>: In an open\u2010label prospective intervention trial, 14 obese well\u2010substituted nondiabetic HPs and 14 matched simple obese controls were allocated to 11\u2010month treatment with sibutramine (10 to 15 mg), diet (600 kcal\/d deficit), and exercise. Anthropometric indices and body composition (obtained from DXA scan) were assessed monthly for the first 5 months and thereafter every second month for the next 6 months.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>: Mean (\u00b1SD) weight loss at 11 months was 11.3 \u00b1 4.8 kg in patients vs. 10.7 \u00b1 4.7 kg in controls. The HPs exhibited the same improvements in body composition, waist circumference, blood lipids, and fasting glucose as the simple obese. In a multivariate model, baseline weight, duration of growth hormone replacement therapy, and duration of pituitary disease explained 79% (<jats:italic>p<\/jats:italic> = 0.001) of the variation in weight loss at 4 months in the HPs. Only baseline weight and waist circumference could predict weight loss at 11 months.<\/jats:p><jats:p><jats:italic>Discussion<\/jats:italic>: HPs are not resistant to weight loss therapy. Almost all will achieve at least 5% weight loss, and 60% can lose &gt;10% weight within 11 months. However, the long\u2010term effect on risk factors associated with type 2 diabetes and cardiovascular disease as well as on mortality needs to be established.<\/jats:p>","DOI":"10.1038\/oby.2004.228","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T09:35:52Z","timestamp":1208770552000},"page":"1835-1843","source":"Crossref","is-referenced-by-count":6,"title":["Combined Dietary and Pharmacological Weight Management in Obese Hypopituitary Patients"],"prefix":"10.1002","volume":"12","author":[{"given":"Henriette","family":"Mersebach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole L.","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Astrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Feldt\u2010Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low\u2010dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C\u2010peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH\u2010deficient adults","volume":"85","author":"Rosenfalck A. M.","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.10.4657"},{"key":"e_1_2_7_4_2","unstructured":"Mersebach H. Sneppen S. B. Feldt\u2010Rasmussen U.Long\u2010term growth hormone treatment improves body composition despite increased BMI. Phoenix Arizona: The 7th International Pituitary Congress 2001 (abstr)107"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91812-O"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01797616"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01559.x"},{"key":"e_1_2_7_8_2","first-page":"275","article-title":"Prognostic markers for diet\u2010induced weight loss in obese women","volume":"19","author":"Astrup A.","year":"1995","journal-title":"Int J Obes Relat Metab Disord."},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030870"},{"issue":"1","key":"e_1_2_7_10_2","first-page":"S30","article-title":"Sibutramine and energy balance","volume":"22","author":"Astrup A.","year":"1998","journal-title":"Int J Obes Relat Metab Disord."},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200210000-00004"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801059"},{"issue":"1","key":"e_1_2_7_13_2","first-page":"S25","article-title":"Sibutramine: a review of the pharmacology of a novel anti\u2010obesity agent","volume":"21","author":"Stock M. J.","year":"1997","journal-title":"Int J Obes Relat Metab Disord."},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/68.6.1180"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801045"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/36.5.936"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00627.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.3.744"},{"key":"e_1_2_7_19_2","volume-title":"Practical Statistics for Medical Research","author":"Altman D. G.","year":"1999"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00411-2"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1995.tb00227.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91499-2"},{"key":"e_1_2_7_23_2","first-page":"129","article-title":"Fluoxetine: a randomized clinical trial in the treatment of obesity","volume":"18","author":"Goldstein D. J.","year":"1994","journal-title":"Int J Obes Relat Metab Disord."},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2000.00071.x"},{"key":"e_1_2_7_25_2","first-page":"156","article-title":"Initial weight loss as predictor of long\u2010term weight loss with sibutramine","volume":"20","author":"Heath M. J.","year":"1996","journal-title":"Int J Obes."},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1999.tb00701.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801930"},{"key":"e_1_2_7_28_2","first-page":"47","article-title":"Correlates and predictors of weight loss in young adults: the CARDIA study","volume":"20","author":"Bild D. E.","year":"1996","journal-title":"Int J Obes Relat Metab Disord."},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801481"},{"key":"e_1_2_7_30_2","first-page":"496","article-title":"The response to treatment of overweight in postmenopausal women is not related to fat distribution","volume":"19","author":"Svendsen O. L.","year":"1995","journal-title":"Int J Obes Relat Metab Disord."},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908053410604"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-45-6-1305"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/78.2.209"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-11359"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856060-00019"},{"key":"e_1_2_7_36_2","first-page":"71","article-title":"Lack of effect of sibutramine on the efficacy of oral contraceptive steroids in healthy women","volume":"11","author":"Back D. J.","year":"1997","journal-title":"Int J Pharm Med."}],"container-title":["Obesity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Foby.2004.228","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1038\/oby.2004.228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T03:35:14Z","timestamp":1698723314000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1038\/oby.2004.228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1038\/oby.2004.228"],"URL":"https:\/\/doi.org\/10.1038\/oby.2004.228","archive":["Portico"],"relation":{},"ISSN":["1071-7323","1550-8528"],"issn-type":[{"value":"1071-7323","type":"print"},{"value":"1550-8528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}